Chrysalis Blog
Six Critical Considerations for Quantitative Market Modeling in the Life Sciences
The market for X is a billion dollars! The demand for Z is going to grow at 18% annually over the next five years! Being quantitative about a potential business opportunity is essential. It’s…
Blog Updates
Six Critical Considerations for Quantitative Market Modeling in the Life Sciences
The market for X is a billion dollars! The demand for Z is going to grow at 18% annually over the next five years! Being quantitative about a…
15 Reasons Genomics Startups Fail
After years spent working with and within startup (and growing), the Chrysalis team has observed repeated themes that prevent good ideas from growing into great companies. The following…
5 Questions With: Erica Ramos
One of the most rapidly evolving intersections of technology and healthcare is in the clinical genomics space. We sought out Erica Ramos, President Elect of the National Society of…
In the Defense of Genome-Wide Association Studies
In case you missed it, you should go back and read the recent article by Visscher et al., “10 Years of GWAS Discovery: Biology, Function, and Translation” in The American…
The Art and Science of Technology/Market Fit
As technologists, R&D scientists, commercial leaders, product managers, business developers and marketers, we’ve collectively seen tens of thousands of technologies, many with the potential to become great products,…
5 Questions With: Robert Green, MD, MPH Professor of Medicine (Genetics), Harvard Medical School
Continuing Chrysalis’ “5 Questions” series, we reached out to Dr. Robert Green, one of the preeminent experts on the clinical use of whole genome sequencing. Thank you Dr. Green…
Not Fake News, NASA Genomics, and Biological Literacy
Part I of our interview with Dr. Chris Mason Throughout our careers, the principals at Chrysalis have built strong, lasting relationships with those pushing the boundaries of genomic…
The Right to Measure Everything: Personal, Cultural, Clinical Metagenomics
Part II of our interview with Dr. Chris Mason. Throughout our careers, the principals at Chrysalis have built strong, lasting relationships with those pushing the boundaries of genomic…
Questions They Wished They’d Asked Sooner: 9 Commercial Issues Life Science Startups Often Overlook
We have seen many companies in the life science space attempt a commercial launch like a ski jumper who forgot to bring along his or her skis. Sure,…